Multivariate analysis of S100A4 expression and tumor subtype, gender, recurrence, IDH status, and MGMT status show that S100A4 is an independent prognostic factor (Multivariate Cox regression analysis p-values: all gliomas = 0.0089, GBM only = 0.0019). This evidence concerns the gene MGMT and glioblastoma.